Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_assertion evidence source_evidence_literature NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_assertion SIO_000772 22653055 NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_assertion wasDerivedFrom befree-20150227 NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_assertion wasGeneratedBy ECO_0000203 NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.